Human Genome Epidemiology Literature Finder
|
Records 1 - 18 (of 18 Records) |
| Query Trace: Carcinoma and VEGFA[original query] |
|---|
| Pazopanib efficacy in renal cell carcinoma: evidence for predictive genetic markers in angiogenesis-related and exposure-related genes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Jun 29 (18): 2557-64. Xu Chun-Fang, Bing Nan X, Ball Howard A, Rajagopalan Dilip, Sternberg Cora N, Hutson Thomas E, de Souza Paul, Xue Zhengyu G, McCann Lauren, King Karen S, Ragone Leigh J, Whittaker John C, Spraggs Colin F, Cardon Lon R, Mooser Vincent E, Pandite Lini |
| The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study. BMC cancer 2012 12 (1): 107. Rutkowski Piotr, Bylina El?bieta, Klimczak Anna, Switaj Tomasz, Falkowski S?awomir, Kroc Jacek, Lugowska Iwona, Brzeskwiniewicz Magdalena, Melerowicz Wojciech, Osuch Czes?aw, Mierzejewska Ewa, Wasielewski Kacper, Wo?niak Agnieszka, Grzesiakowska Urszula, Nowecki Zbigniew I, Siedlecki Janusz A, Limon Janu |
| Vascular endothelial growth factor A gene (VEGFA) polymorphisms and expression of VEGFA gene in lung cancer patients of Kashmir Valley (India). Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2012 Jun 33 (3): 833-9. Naik Niyaz A, Bhat Imtiyaz A, Afroze Dil, Rasool Roohi, Mir Hyder, Andrabi Syed Irtiza, Shah Sonaullah, Siddiqi Mushtaq A, Shah Zafar |
| Polymorphisms in the VEGFA promoter are associated with susceptibility to hepatocellular carcinoma by altering promoter activity. International journal of cancer. Journal international du cancer 2013 Sep 133 (5): 1085-93. Wu Xiaopan, Xin Zhenhui, Zhang Wei, Wu Jia, Chen Kangmei, Wang Huifen, Zhu Xilin, Pan Liping, Li Zhuo, Li Hui, Liu Yi |
| Variants in angiogenesis-related genes and the risk of clear cell renal cell carcinoma. Mutagenesis 2014 Nov 29 (6): 419-25. Qin Chao, Chen Jianchun, Li Jie, Ju Xiaobing, Zhang Shaobo, Cao Qiang, Han Zhijian, Li Pu, Shao Peifei, Wang Meilin, Zhang Zhengdong, Gu Min, Zhang Wei, Yin Changj |
| Genetic polymorphisms of proangiogenic factors seem to favor hepatocellular carcinoma development in alcoholic cirrhosis. European journal of gastroenterology & hepatology 2014 Apr 26 (4): 438-43. Machado Mariana V, Janeiro André, Miltenberger-Miltenyi Gabriel, Cortez-Pinto Hele |
| Evaluation of polymorphisms in angiogenesis-related genes as predictive and prognostic markers for sunitinib-treated metastatic renal cell carcinoma patients. Journal of cancer research and clinical oncology 2016 Mar . Dornbusch Juana, Walter Martina, Gottschalk Andrea, Obaje Alice, Junker Kerstin, Ohlmann Carsten-Henning, Meinhardt Matthias, Zacharis Aristeidis, Zastrow Stefan, Schoffer Olaf, Grimm Marc-Oliver, Klug Stefanie J, Wirth Manfred P, Fuessel Susan |
| A Comprehensive Meta-analysis of Case-Control Association Studies to Evaluate Polymorphisms Associated with the Risk of Differentiated Thyroid Carcinoma. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2016 Feb . Figlioli Gisella, Elisei Rossella, Romei Cristina, Melaiu Ombretta, Cipollini Monica, Bambi Franco, Chen Bowang, Köhler Aleksandra, Cristaudo Alfonso, Hemminki Kari, Gemignani Federica, Försti Asta, Landi Stefa |
| Association between single nucleotide variants of vascular endothelial growth factor A and the risk of thyroid carcinoma and nodular goiter in a Han Chinese population. Oncotarget 2017 Feb . Liu Rui, Ning Lifeng, Liu Xiaoli, Zhang Huiping, Yu Yaqin, Zhang Shangchao, Rao Wenwang, Shi Jieping, Sun Hui, Yu Qio |
| Association of VEGFA polymorphisms with susceptibility and clinical outcome of hepatocellular carcinoma in a Chinese Han population. Oncotarget 2017 Jan . Liu Fei, Luo Limei, Wei Yonggang, Wang Wentao, Wen Tianfu, Yang Jiayin, Xu Mingqing, Li |
| Paclitaxel With and Without Pazopanib for Persistent or Recurrent Ovarian Cancer: A Randomized Clinical Trial. JAMA oncology 2017 12 4 (2): 196-202. Richardson Debra L, Sill Michael W, Coleman Robert L, Sood Anil K, Pearl Michael L, Kehoe Siobhan M, Carney Michael E, Hanjani Parviz, Van Le Linda, Zhou Xun C, Alvarez Secord Angeles, Gray Heidi J, Landrum Lisa M, Lankes Heather A, Hu Wei, Aghajanian Car |
| Effects of VEGF and VEGFR polymorphisms on the outcome of patients with metastatic renal cell carcinoma treated with sunitinib: a systematic review and meta-analysis. Oncotarget 2017 Sep 8 (40): 68854-68862. Miao Chenkui, Cao Jingyi, Wang Yuhao, Liu Bianjiang, Wang Zengj |
| Single nucleotide polymorphisms as prognostic and predictive biomarkers in renal cell carcinoma. Oncotarget 2017 Dec 8 (63): 106551-106564. Garrigós Carmen, Espinosa Marta, Salinas Ana, Osman Ignacio, Medina Rafael, Taron Miguel, Molina-Pinelo Sonia, Duran Ignac |
| Genetic Heterogeneity of Esophageal Squamous Cell Carcinoma with Inherited Family History. OncoTargets and therapy 2020 13 8795-8802. He Wenwu, Leng Xuefeng, Yang Yanyu, Peng Lin, Shao Yang, Li Xue, Han Yongt |
| Comprehensive analysis of mutations of renal cell carcinoma in an autosomal dominant polycystic kidney disease patient. Medicine 2020 5 99 (19): e20071. Shim Kwang Eon, Lee Chung, Kim Jin Up, Choi Gwang Ho, Kwak Kyoung Min, Kim Seok Hyung, Kim Hyunho, Yoon Jong Woo, Shin Tae Young, Jeong Chang Wook, Kim Hyuns |
| Genetic Variations of VEGFA Gene Are Associated With Infiltration of Adjacent Tissues and the Clinical Outcome of Patients With Nasopharyngeal Carcinoma. Anticancer research 2020 Feb 40 (2): 677-688. Psoma Elizabeth, Koliou Georgia-Angeliki, Dimitrakopoulos Foteinos-Ioannis, Papadopoulou Kyriaki, Rontogianni Dimitra, Bobos Mattheos, Visvikis Anastasios, Kosmidis Paris A, Fountzilas George, Constantinidis Jannis, Kalogera-Fountzila An |
| Methylene tetrahydrofolate reductase (MTHFR) and vascular endothelial growth factor (VEGF) polymorphisms in Brazilian patients with Hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC). Clinics (Sao Paulo, Brazil) 2021 76 e2881. Carvalho Sylene C R, Vasconcelos Luydson R S, Fonseca Leonardo da, Carmo Rodrigo F, Tomitão Michele T, Aroucha Dayse C B L, Pereira Leila M M B, Stefano José Tadeu, Ribeiro-Júnior Ulysses, Oliveira Claudia P, Carrilho Flair |
| c-MET/VEGFR-2 co-localisation impacts on survival following bevacizumab therapy in epithelial ovarian cancer: an exploratory biomarker study of the phase 3 ICON7 trial. BMC medicine 2022 Feb 20 (1): 59. Morgan Robert D, Ferreras Cristina, Peset Isabel, Avizienyte Egle, Renehan Andrew G, Edmondson Richard J, Murphy Alexander D, Nicum Shibani, Van Brussel Thomas, Clamp Andrew R, Lambrechts Diether, Zhou Cong, Jayson Gordon |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 25, 2023
- Content source: